3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
67
Breast Neoplasms, Male
4
Neoplasm Metastasis
3
Neoplasms
2
Advanced Breast Cancer
2
Unilateral Breast Neoplasms
1
Sleep Wake Disorders
1
Recurrence
1
Ovarian Neoplasms
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
First Line Metastatic Breast Cancer
1
Fatigue
1
Carcinoma, Intraductal, Noninfiltrating
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Breast Cancer Female
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
enzalutamide
2
ostarine
1
exemestane
1
abiraterone
1
Prednisolone
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Bulbo-Spinal Atrophy, X-Linked
×
exemestane
×
Clear all
NCT04869943
2024-01-26
ARTEST
Veru Inc.
Phase 3
Terminated
52 enrolled